Zetia, Vytorin reduce risk of repeat heart attacks

November 17, 2014 5:55 PM

11 0

Lower truly may be better when it comes to cholesterol, according to a new study that finds that adding another drug to a statin to bring down levels of LDL or "bad" cholesterol modestly helps recent heart attack victims.

The Merck drugs Zetia and Vytorin, which had combined worldwide sales of $3 billion so far this year, were shown to reduce the risk of repeat heart attacks or stroke by about 6%, according to the study, which is being presented today at the American Heart Association's annual conference in Chicago.

Read more

To category page